Yayınlar & Eserler

Yayın Ağı
Makaleler 17
Tümü (17)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (17)
ESCI (2)
Scopus (16)
TRDizin (1)

1. Investigating the FIB-4 index and PET/CT metabolic parameters for the differentiation status of hepatocellular carcinoma

Ciftci E., Gulbagci B., Gumusgoz H. S., AKOVALI B., Erkek B. K.
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.17, ss.167-171, 2026 (ESCI) Creative Commons License identifier

2. Predictive value of the 68Ga-PSMA-11 PET/CT PRIMARY score for pathological upgrading in patients with ISUP Grade 1 prostate cancer and PSA < 20 ng/mL undergoing radical prostatectomy

Ciftci E., AKOVALI B., Gumusgoz H. S., Erkek B. K.
Annals of Nuclear Medicine , 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

3. Why so many doses, and why now?

BİLGİÇ S., AKOVALI B.
European Thyroid Journal , cilt.14, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. THE RELATIONSHIP BETWEEN TUMOR MEAN STANDARD UPTAKE VALUE (SUVMAX) IN PREOPERATIVE PET/COMPUTED TOMOGRAPHY AND PROGNOSTIC RISK GROUPS IN ENDOMETRIAL CANCER

Bese T. T., Bicer E., Kosuk A. T., AKOVALI B., Turan H., Kabasakal L., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.33, 2023 (SCI-Expanded, Scopus) identifier

5. The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer

Bese T., Bicer E., Kosuk A. T., AKOVALI B., Turan H., Kabasakal L., et al.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.44, sa.3, ss.204-211, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Breast cancer to thyroid gland: An unconventional metastatic site

Celik E., Ozturk T., Samanci N. S., DEMİRCİ N. S., AKOVALI B., Demirelli F. H.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.18, sa.3, ss.788-791, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging

Akyel R., Akgun E., AKOVALI B., ŞAHİN O. E., SAĞER M. S., AÇIKGÖZ A. S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, sa.2, ss.174-181, 2022 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

8. Complete response after ceritinib treatment in non-small cell lung cancer in an elderly patient

Sengul Samanci N., Celik E., AKOVALI B., SAĞER M. S., Demirelli F. H.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.8, ss.2031-2033, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. The impact of different computational assumptions in131I dosimetry for hyperthyroidism therapy

Abuqbeitah M., SAĞER M. S., DEMİR M., YEYİN N., AKOVALI B., SÖNMEZOĞLU K.
MEDICAL PHYSICS , cilt.47, sa.11, ss.5810-5816, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Hyperprogression after nivolumab for melanoma: A case report

Yilmaz M., AKOVALI B.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.1, ss.244-251, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

SAĞER M. S., Akgun E., USLU BEŞLİ R. L., ASA S., AKOVALI B., ŞAHİN O. E., et al.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.5, ss.461-468, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. The Importance Of Ga-68 PSMA PET CT In Detection Of Recurrence Metastasis Prostate Cancer Without Biochemical Recurrence

AKGÜN E., ŞAHİN O. E., Demirci E., AKOVALI B., DEMİRCİ M., AYGÜN A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus) identifier

13. Comparison of Therapy Response Between PERCIST and RECIST Criteria After Yttrium-90 Therapy in HCC Patients

SAĞER M. S., Akgun E., USLU BEŞLİ R. L., Asa S., ŞAHİN O. E., AKOVALI B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus) identifier

14. Efficacy and Safety of 177Lu-PSMA-617 Treatment in Castration Resistant Prostate Cancer with Organ Metastasis

ŞAHİN O. E., Akgun E., Demirci E., Ocak M., Akgun A., AKOVALI B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus) identifier

15. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., Nematyazar J., KABASAKAL L.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.11, ss.1169-1179, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Normal Distribution Pattern and Physiological Variants of Ga-68-PSMA PET/CT

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., KABASAKAL L.
JOURNAL OF NUCLEAR MEDICINE , cilt.57, 2016 (SCI-Expanded, Scopus) identifier

17. The clinical and biochemical presentation of vitamin D deficiency and insufficiency in children and adolescents

Torun E., Genc H., Gonullu E., AKOVALI B., Ozgen I. T.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.26, sa.5-6, ss.469-475, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. Survival Analysis of Advanced HCC Treated with Yttrium-90 Radioembolization: A 10-year single-center experience

Bilgic S., SAĞER M. S., AKOVALI B., ŞAHİN O. E., Kaymak E., USLU BEŞLİ R. L., et al.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

2. Contribution of 68Ga-PSMA-11 PET/CT imaging in Gleason Score 3+3=6 Prostate Cancer

ŞAHİN O. E., Gilgic S., SAĞER M. S., AKOVALI B., AKGÜN E., USLU BEŞLİ R. L., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) identifier

3. Selective Internal Radiation Therapy (SIRT) for Liver Metastasis of Chemoresistant Breast Cancer: Overall Survival and Dose - Response Relationship

AKOVALI B., Akgun E. K., ŞAHİN O. E., YEYİN N., Abuqbeitah M., Tanyildizi H., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) identifier

4. 68Ga-DOTA-TATE PET-CT in differentiated thyroid cancer patients: comparison with 18F-FDG PET-CT

Vatankulu B., AKOVALI B., SAĞER M. S., Halac M., KABASAKAL L., SÖNMEZOĞLU K.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

5. Normal Distribution Pattern and Physiological Variants of Ga-68-PSMA PET/CT

Demirci E., ŞAHİN O. E., Ocak M., AKOVALI B., Nematyazar J., KABASAKAL L.
Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri) identifier

6. CINCA syndrome in an infant presenting with hydrocephalus

Turel O., Uzunel S., Keskin O., AKOVALI B., ERENBERK U., Tatli B.
European Congress of Immunology, Glasgow, İngiltere, 5 - 08 Eylül 2012, cilt.137, ss.524, (Özet Bildiri) identifier
Metrikler

Yayın

23

Yayın (WoS)

23

Yayın (Scopus)

16

Atıf (WoS)

172

H-İndeks (WoS)

4

Atıf (Scopus)

186

H-İndeks (Scopus)

4

Atıf (Scholar)

284

H-İndeks (Scholar)

5

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları